Some of our supporters from previous years
Biotech, Healthcare, IT, Life Sciences, Pharma
The European annual biotech conference
Biotech Atelier 2022
Save the date / 28 – 30 Sep 2022
Key Topics 2022
Current Trends of Medicine of Today
Patients’ Empowerment and Health Outcomes
Digital Health and Solutions: New Horizons
Advertizing
Advertizing
А sneak peek of our
Speakers in 2022
Meet those that challenge the status quo – futurists, innovators and distinguished international experts working on actual projects. We will announce over 70 speakers prior to the conference dates.
USA
Jeff Wallace
Adjunct Instructor at UC Berkeley for Entrepreneurship and Innovation
Co-founder of Silicon Valley in Your Pocket
Bulgaria
Jana Makedonska
Programme Manager
Health Research Unit of the European Health and Digital Executive Agency (HaDEA)
The Netherlands
Peter Kapitein, Dr. H. C.
International networker in cancer research
Patient Advocate at Inspire2Live
Belgium
Koen Kas, Prof. Dr.
Healthcare futurist & delight thinker
Guest professor at Ghent University in Belgium
Why attend our conference?
Futurists. Business leaders. Investors. Think tanks. Scientists. Entrepreneurs. And You!
Speakers from around the globe will share their firsthand experience, insider information and expectations for the future. Meet the relevant stakeholders across the value chain and understand their perspective on current topics. Create your very own future action plan and meet the people you need to make a success out of it. Biotech Atelier gives you the opportunity to encounter relevant industry leaders from all 5 sectors, gain cross-vertical knowledge and come up with your find your next business partners.
Discover
Discover the latest and greatest from your fields of interest.
Meet
Meet with all relevant stakeholders.
Create
Create a master plan for your future business.
Check out previous events of Biotech Atelier
Innovative Health Initiative (IHI) Webinar
Don't let Cancer become the Forgotten C in the Fight against COVID-19
by Prof. Dr. Mark Lawler
A patient’s view of CAR-T Cell Therapy
by Jonathan Clark